KAHOOK MALIK Y. enters SPYGLASS PHARMA, INC. with 873.98K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/5/2026ACC: 0002106409-26-000002
DirectorOfficer· See remarks
Since Feb 2026
873.98K
Baseline shares
100% direct
873.98K
Direct ownership
1 position
434.74K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned873.98K
Total
873.98K direct873.98K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 873.98K | Direct |
| Total | 873.98K | 873.98K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
191.87K
Shares owned
N/A
Exercise price
2.87
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
170.47K
Shares owned
N/A
Exercise price
7.11
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
72.39K
Shares owned
N/A
Exercise price
2.18
Expiration
—
Exercise window
—
Total
Underlying
434.74K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 2.87 | — | — | 191.87K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.11 | — | — | 170.47K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 2.18 | — | — | 72.39K | N/A |
| Total | 434.74K | 0.00 | ||||